When doctors and nurses are faced with a shortage of medically necessary drugs, they are forced to make challenging decisions about how to ration whatever they have left.
FDA commissioner Dr. Scott Gottlieb is looking to identify ways that the U.S. regulatory agency can help prevent and predict these shortages. In a statement this week, Gottlieb revealed that he’s even considering working with Congress to expand the FDA’s existing authority to require pharmaceutical manufacturers to conduct shortage risk assessments.
Get the full story at our sister site, Drug Delivery Business News.
The post FDA’s Gottlieb: Drug shortages are an ‘inevitable consequence of an imperfect system’ appeared first on MassDevice.
from MassDevice https://ift.tt/2sqeLBb
Cap comentari:
Publica un comentari a l'entrada